See every side of every news story
Published loading...Updated

Grifols to make €350-million takeover bid for Biotest capital it does not yet control, with aim of delisting it

Summary by The Corner
The Corner Bankinter | The company’s Board of Directors has unanimously approved that its subsidiary Grifols Biotest Holdings make a public takeover bid to delist Biotest AG from the stock exchange. The bid will be for the 2.9% of the ordinary shares it does not control and 53.8% of the preference shares. It will offer €43.00 for each ordinary share and €30.00 for each preference share. In addition, it will request the...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Corner broke the news in on Thursday, April 3, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.